Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep. 2024 Jul 4;14(1):15395. doi: 10.1038/s41598-024-64986-6.
The APOBEC/AID family is known for its mutator activity, and recent evidence also supports the potential impact of ADARs. Furthermore, the mutator impacts of APOBEC/ADAR mutations have not yet been investigated. Assessment of pancancer TCGA exomes identified enriched somatic variants among exomes with nonsynonymous APOBEC1, APOBEC3B, APOBEC3C, ADAR, and ADARB1 mutations, compared to exomes with synonymous ones. Principal component (PC) analysis reduced the number of potential players to eight in cancer exomes/genomes, and to five in cancer types. Multivariate regression analysis was used to assess the impact of the PCs on each COSMIC mutational signature among pancancer exomes/genomes and particular cancers, identifying several novel links, including SBS17b, SBS18, and ID7 mainly determined by APOBEC1 mRNA levels; SBS40, ID1, and ID2 by age; SBS3 and SBS16 by APOBEC3A/APOBEC3B mRNA levels; ID5 and DBS9 by DNA repair/replication (DRR) defects; and SBS7a-d, SBS38, ID4, ID8, ID13, and DBS1 by ultraviolet (UV) radiation/ADARB1 mRNA levels. APOBEC/ADAR mutations appeared to potentiate the impact of DRR defects on several mutational signatures, and some factors seemed to inversely affect certain signatures. These findings potentially implicate certain APOBEC/ADAR mutations/mRNA levels in distinct mutational signatures, particularly APOBEC1 mRNA levels in aging-related signatures and ADARB1 mRNA levels in UV radiation-related signatures.
APOBEC/AID 家族以其突变活性而闻名,最近的证据也支持 ADAR 的潜在影响。此外,APOBEC/ADAR 突变的突变影响尚未得到研究。在泛癌 TCGA 外显子组中进行评估,与同义外显子相比,在具有非同义 APOBEC1、APOBEC3B、APOBEC3C、ADAR 和 ADARB1 突变的外显子组中鉴定出丰富的体细胞变体。主成分 (PC) 分析将癌症外显子/基因组中的潜在参与者数量减少到 8 个,癌症类型中的潜在参与者数量减少到 5 个。多元回归分析用于评估 PCs 在泛癌外显子/基因组和特定癌症中的每个 COSMIC 突变特征上的影响,确定了几个新的联系,包括 SBS17b、SBS18 和 ID7 主要由 APOBEC1 mRNA 水平决定;SBS40、ID1 和 ID2 由年龄决定;SBS3 和 SBS16 由 APOBEC3A/APOBEC3B mRNA 水平决定;ID5 和 DBS9 由 DNA 修复/复制 (DRR) 缺陷决定;SBS7a-d、SBS38、ID4、ID8、ID13 和 DBS1 由紫外线 (UV) 辐射/ADARB1 mRNA 水平决定。APOBEC/ADAR 突变似乎增强了 DRR 缺陷对几种突变特征的影响,一些因素似乎会对某些特征产生相反的影响。这些发现可能暗示某些 APOBEC/ADAR 突变/mRNA 水平与不同的突变特征有关,特别是 APOBEC1 mRNA 水平与衰老相关特征有关,ADARB1 mRNA 水平与 UV 辐射相关特征有关。